{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T18:43:26Z","timestamp":1783017806391,"version":"3.54.6"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100019383","name":"Cipla Ltd","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019383","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s40801-025-00534-6","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T14:37:12Z","timestamp":1767623832000},"page":"63-71","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of Effectiveness and Safety of Telmisartan and Amlodipine Fixed-Dose Combination in Indian Patients with Hypertension: TACT-India Study"],"prefix":"10.1007","volume":"13","author":[{"given":"Ashok Kumar","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangesh","family":"Tiwaskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jabir","family":"Abdullakutty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arindam","family":"Pande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viveka","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Febin","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Zalte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9207-5605","authenticated-orcid":false,"given":"Amarnath","family":"Sugumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandesh","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthilnathan","family":"Mohanasundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"1","key":"534_CR1","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1186\/s12889-024-20097-5","volume":"24","author":"R Mohammad","year":"2024","unstructured":"Mohammad R, Bansod DW. Hypertension in India: a gender-based study of prevalence and associated risk factors. BMC Public Health. 2024;24(1):2681.","journal-title":"BMC Public Health"},{"issue":"10","key":"534_CR2","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1016\/j.clinthera.2016.09.006","volume":"38","author":"CG Park","year":"2016","unstructured":"Park CG, Ahn TH, Cho EJ, Kim W, Kim HS, Yang JY, et al. Comparison of the efficacy and safety of fixed-dose S-amlodipine\/telmisartan and telmisartan in hypertensive patients inadequately controlled with telmisartan: a randomized, double-blind, multicenter study. Clin Ther. 2016;38(10):2185\u201394.","journal-title":"Clin Ther"},{"issue":"10258","key":"534_CR3","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","volume":"396","author":"CJ Murray","year":"2020","unstructured":"Murray CJ, Aravkin AY, Zheng P, Abbafati C, Abbas KM, Abbasi-Kangevari M, et al. Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223\u201349.","journal-title":"Lancet"},{"issue":"23","key":"534_CR4","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/eurheartj\/ehac395","volume":"44","author":"L Lauder","year":"2023","unstructured":"Lauder L, Mahfoud F, Azizi M, Bhatt DL, Ewen S, Kario K, et al. Hypertension management in patients with cardiovascular comorbidities. Eur Heart J. 2023;44(23):2066\u201377.","journal-title":"Eur Heart J"},{"issue":"10304","key":"534_CR5","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","volume":"398","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2021","unstructured":"NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957\u201380.","journal-title":"Lancet"},{"issue":"11","key":"534_CR6","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.59556\/japi.72.0743","volume":"72","author":"AK Das","year":"2024","unstructured":"Das AK, Tiwaskar M, Abdullakutty J, Pande A, Kumar V, Zalte N, et al. Effectiveness and safety of the telmisartan and amlodipine fixed-dose combination in managing hypertension among Indian patients (TACT India study): rationale and study design. J Assoc Physicians India. 2024;72(11):e16-20.","journal-title":"J Assoc Physicians India"},{"issue":"38","key":"534_CR7","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension: developed by the task force on the management of elevated blood pressure and hypertension of the European Society of Cardiology (ESC) and endorsed by the European Society of Endocrinology (ESE) and the European Stroke Organisation (ESO). Eur Heart J. 2024;45(38):3912\u20134018.","journal-title":"Eur Heart J"},{"issue":"2","key":"534_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2016-000473","volume":"3","author":"H Fares","year":"2016","unstructured":"Fares H, DiNicolantonio JJ, O\u2019Keefe JH, Lavie CJ. Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes. Open Heart. 2016;3(2):e000473.","journal-title":"Open Heart"},{"key":"534_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116169","volume":"171","author":"M Imenshahidi","year":"2024","unstructured":"Imenshahidi M, Roohbakhsh A, Hosseinzadeh H. Effects of telmisartan on metabolic syndrome components: a comprehensive review. Biomed Pharmacother. 2024;171:116169.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"534_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3810\/pgm.2009.03.1972","volume":"121","author":"TW Littlejohn","year":"2009","unstructured":"Littlejohn TW, Majul CR, Olvera R, Seeber M, Kobe M, Guthrie R. Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4\u00d74 factorial study. Postgrad Med. 2009;121(2):5\u201314.","journal-title":"Postgrad Med"},{"issue":"7","key":"534_CR11","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1751-7176.2011.00468.x","volume":"13","author":"S Neldam","year":"2011","unstructured":"Neldam S, Lang M, Jones R, TEAMSTA\u20105 Investigators. Telmisartan and amlodipine single-pill combinations vs amlodipine monotherapy for superior blood pressure lowering and improved tolerability in patients with uncontrolled hypertension: results of the TEAMSTA-5 study. J Clin Hypertens. 2011;13(7):459\u201366.","journal-title":"J Clin Hypertens"},{"issue":"12","key":"534_CR12","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH guidelines for the management of arterial hypertension The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874\u20132071.","journal-title":"J Hypertens"},{"key":"534_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2024.05.033","volume":"126","author":"R Kreutz","year":"2024","unstructured":"Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, Muiesan ML, et al. 2024 European Society of Hypertension clinical practice guidelines for the management of arterial hypertension. Eur J Intern Med. 2024;126:1\u201315.","journal-title":"Eur J Intern Med"},{"key":"534_CR14","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.17760","volume":"12","author":"L Li","year":"2024","unstructured":"Li L, Duan L, Xu Y, Ruan H, Zhang M, Zheng Y, et al. Hypertension in frail older adults: current perspectives. PeerJ. 2024;12:e17760.","journal-title":"PeerJ"},{"issue":"7","key":"534_CR15","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/hr.2013.10","volume":"36","author":"M Ohishi","year":"2013","unstructured":"Ohishi M, Kawai T, Hayashi N, Kitano S, Katsuya T, Nagano M, et al. Effect of tablets with a combination of telmisartan and amlodipine on patients with hypertension: the Cotalo study. Hypertens Res. 2013;36(7):620\u20136.","journal-title":"Hypertens Res"},{"issue":"4","key":"534_CR16","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1751-7176.2009.00098.x","volume":"11","author":"TW Littlejohn 3rd","year":"2009","unstructured":"Littlejohn TW 3rd, Majul CR, Olvera R, Seeber M, Kobe M, Guthrie R, et al. Results of treatment with telmisartan-amlodipine in hypertensive patients. J Clin Hypertens (Greenwich). 2009;11(4):207\u201313.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"534_CR17","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.2165\/11594510-000000000-00000","volume":"71","author":"C Su\u00e1rez","year":"2011","unstructured":"Su\u00e1rez C. Single-pill telmisartan and amlodipine: a rational combination for the treatment of hypertension. Drugs. 2011;71:2295\u2013305.","journal-title":"Drugs"},{"key":"534_CR18","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.urology.2017.02.056","volume":"107","author":"K Davis","year":"2017","unstructured":"Davis K, Bellini P, Hagerman C, Zinar R, Leigh D, Hoffman R, et al. Physicians\u2019 perceptions of factors influencing the treatment decision-making process for men with low-risk prostate cancer. Urology. 2017;107:86\u201395.","journal-title":"Urology"}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-025-00534-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40801-025-00534-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-025-00534-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T14:40:17Z","timestamp":1773931217000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40801-025-00534-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["534"],"URL":"https:\/\/doi.org\/10.1007\/s40801-025-00534-6","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"value":"2199-1154","type":"print"},{"value":"2198-9788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"7 December 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Febin Francis, Nitin Zalte, Amarnath Sugumaran, Sandesh Sawant, and Senthilnathan Mohanasundaram are\/were employees of Cipla Ltd. All other authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The protocol of the study was approved by an independent ethics committee (Suraksha\u2014Ethics Committee, Asian Institute of Medical Sciences [AIMS], Dombivli, Maharashtra, India) on 31 August 2023 prior to the commencement of the study. The study was performed in accordance with the standards of ethics outlined in the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Written informed consent was obtained from each participant before their enrollment.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"The data supporting the findings of this study are available from the corresponding author upon reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship for this article, take responsibility for the integrity of the work. Conceptualization: A.K.D., M.T., and J.A. Methodology: J.A., A.P., V.K., F.F., N.Z., and A.S. Formal analysis: F.F., N.Z., and S.S. Investigation: A.K.D., M.T., J.A., A.P., V. K., F.F., N.Z., and S.S. Resources: A.S., S.S., and S.M. Writing\u2014original draft preparation: A.K.D., A.P., S.S., F.F., A.S., and S.M. Writing\u2014review and editing: A.K.D., M.T., J.A., A.P., V.K., and S.M. Visualization: S.M. Supervision: M.T., V.K., F.F., N.Z., A.S., and S.S. Project administration: F.F. and S.M. All authors have read and agreed to the published version of the manuscript.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}